clinical 2,866 words KG: CBS Natural History Study (NCT06691234) 2026-03-28
kind:clinical-trialsection:clinical-trialsstate:published
Contents

CBS Natural History Study (NCT06691234)

Knowledge Graph

Related Hypotheses (12)

Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51
Glymphatic-Mediated Tau Clearance Dysfunction
Score: 0.55
Dual-Circuit Tau Vulnerability Cascade
Score: 0.50
Dopaminergic Ventral Tegmental-Hippocampal Circuit Protectio
Score: 0.49
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59

Related Analyses (2)

APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed

Related Experiments (10)

CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi
validation · proposed · Score: 0.40
N-of-1 Clinical Trial Design for CBS/PSP
clinical · proposed · Score: 0.40
4R-Tau Targeting Therapies for PSP and CBS
clinical · proposed · Score: 0.40
ALS Progression Rate Heterogeneity — mechanism and biomarker
clinical · proposed · Score: 0.40
CRISPR Gene Correction Approaches for CBS/PSP
clinical · proposed · Score: 0.40

Knowledge Graph (1 edges)

CBS Natural History Study (NCT06691234) references APOE